893 related articles for article (PubMed ID: 9015760)
1. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
Ahmad F; Goldstein BJ
J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
[TBL] [Abstract][Full Text] [Related]
2. Differential expression and translocation of protein tyrosine phosphatase 1B-related proteins in ME-180 tumor cells expressing apoptotic sensitivity and resistance to tumor necrosis factor: potential interaction with epidermal growth factor receptor.
Perez M; Haschke B; Donato NJ
Oncogene; 1999 Jan; 18(4):967-78. PubMed ID: 10023672
[TBL] [Abstract][Full Text] [Related]
3. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
Donato NJ; Ince C; Rosenblum MG; Gallick GE
J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
Wang X; Weng LP; Yu Q
Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
[TBL] [Abstract][Full Text] [Related]
5. The protein tyrosine phosphatase LAR has a major impact on insulin receptor dephosphorylation.
Mooney RA; Kulas DT; Bleyle LA; Novak JS
Biochem Biophys Res Commun; 1997 Jun; 235(3):709-12. PubMed ID: 9207225
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.
Lorenzo M; Fernández-Veledo S; Vila-Bedmar R; Garcia-Guerra L; De Alvaro C; Nieto-Vazquez I
J Anim Sci; 2008 Apr; 86(14 Suppl):E94-104. PubMed ID: 17940160
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling.
Kroder G; Bossenmaier B; Kellerer M; Capp E; Stoyanov B; Mühlhöfer A; Berti L; Horikoshi H; Ullrich A; Häring H
J Clin Invest; 1996 Mar; 97(6):1471-7. PubMed ID: 8617880
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the cytotoxic activity of tumor necrosis factor by protein tyrosine kinase and protein tyrosine phosphatase inhibitors.
Mishra S; Mathur R; Hamburger AW
Lymphokine Cytokine Res; 1994 Apr; 13(2):77-83. PubMed ID: 8061118
[TBL] [Abstract][Full Text] [Related]
9. Protein tyrosine phosphatase regulation in fibroblasts from patients with an insulin receptor gene mutation.
Seki N; Yagi S; Suzuki Y; Shimada F; Taira M; Makino H; Amano K; Yagui K; Saito Y; Hashimoto N
Horm Metab Res; 2008 Dec; 40(12):833-7. PubMed ID: 18925540
[TBL] [Abstract][Full Text] [Related]
10. Cell density-dependent changes in the insulin action pathway: evidence for involvement of protein-tyrosine phosphatases.
Li PM; Goldstein BJ
J Cell Biochem; 1996 Apr; 61(1):31-8. PubMed ID: 8726353
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor regulates tyrosine phosphorylation on epidermal growth factor receptors in A431 carcinoma cells: evidence for a distinct mechanism.
Donato NJ; Rosenblum MG; Steck PA
Cell Growth Differ; 1992 May; 3(5):259-68. PubMed ID: 1378752
[TBL] [Abstract][Full Text] [Related]
12. Role of PI 3-kinase and SH-PTP2 in insulin action.
Kasuga M
Diabet Med; 1996 Sep; 13(9 Suppl 6):S87-9. PubMed ID: 8894489
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
Batty IH; Fleming IN; Downes CP
Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha: a continuum of liability between insulin-dependent diabetes mellitus, non-insulin-dependent diabetes mellitus and carcinoma (review).
Holden RJ; Pakula IS; Mooney PA
Med Hypotheses; 1999 Apr; 52(4):319-23. PubMed ID: 10465670
[TBL] [Abstract][Full Text] [Related]
15. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
[TBL] [Abstract][Full Text] [Related]
16. The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells.
Suárez Pestana E; Tenev T; Gross S; Stoyanov B; Ogata M; Böhmer FD
Oncogene; 1999 Jul; 18(28):4069-79. PubMed ID: 10435588
[TBL] [Abstract][Full Text] [Related]
17. Suppression of insulin receptor activation by overexpression of the protein-tyrosine phosphatase LAR in hepatoma cells.
Li PM; Zhang WR; Goldstein BJ
Cell Signal; 1996 Nov; 8(7):467-73. PubMed ID: 9023010
[TBL] [Abstract][Full Text] [Related]
18. Association of insulin receptor substrate 3 with SH2 domain-containing proteins in rat adipocytes.
Ross SA; Lienhard GE; Lavan BE
Biochem Biophys Res Commun; 1998 Jun; 247(2):487-92. PubMed ID: 9642156
[TBL] [Abstract][Full Text] [Related]
19. Role of intracellular Ca2+ in the epidermal growth factor induced inhibition of protein tyrosine phosphatase activity in a breast cancer cell line.
Mishra S; Hamburger AW
Biochem Biophys Res Commun; 1993 Mar; 191(3):1066-72. PubMed ID: 7682060
[TBL] [Abstract][Full Text] [Related]
20. Insulin receptor kinase phosphorylates protein tyrosine phosphatase containing Src homology 2 regions and modulates its PTPase activity in vitro.
Maegawa H; Ugi S; Adachi M; Hinoda Y; Kikkawa R; Yachi A; Shigeta Y; Kashiwagi A
Biochem Biophys Res Commun; 1994 Mar; 199(2):780-5. PubMed ID: 8135823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]